Lineage, Inc. heads into July with its ORTEX short score at a six-week high, shorts increasing at an accelerating pace, and the stock giving back nearly half its weekly gain in a single session.
The most striking development this week is the speed of the short-score move. The ORTEX short score climbed from 60.5 on June 23 to 70.6 by June 30 — a ten-point jump in one week. That puts it in the 5th percentile of its sector on short score rank, meaning bears are building a more assertive case for this name than for almost any other industrial REIT right now. The catalyst is clearly the jump in short interest: shorts added roughly 18% to their position over the week, pushing the share count borrowed to 9.1 million. Over the past month, short interest has grown 38%, from around 6.6 million shares in late May to the current level. At 4% of free float, it has crossed a threshold where the position is no longer trivial.
The borrow market is tightening in parallel, though it still has room to run. Cost to borrow more than doubled over the week, reaching 0.87% on June 30 from 0.43% the prior Monday — a 103% rise in seven days. That is still an inexpensive borrow in absolute terms, so the market is not yet pricing in genuine squeeze risk. Availability has dropped sharply, falling to 270% — compared to levels above 800% through most of June and above 1,100% in late May — but it remains in the "tight" range rather than signalling supply stress. Options positioning confirms a measured rather than panicked setup: the put/call ratio at 0.52 is only modestly above its 20-day mean of 0.48, with a z-score below 0.5. There is no unusual demand for downside protection. Positioning looks more like deliberate bearish accumulation than a defensive scramble.
The Street offers a split picture. The most recent analyst action, from Evercore ISI on July 1, raised the target to $47 while keeping an In-Line rating — consistent with a view that the stock merits fair value, not a re-rating. Morgan Stanley raised its target to $47 in early June from $39. Truist has a $46 Buy. But Wells Fargo cut its target to $36, and Barclays holds an Underweight with a $35 target. The mean analyst target of $43.16 is almost exactly where the stock trades at $43.25, which explains the weight of neutral ratings: the Street collectively sees little margin of safety at current levels. The bull case centres on double-digit productivity gains and a recovery in occupancy through the second half of 2026. Bears counter that the EV/EBITDA of 14.2x remains full for a business facing low-single-digit same-store NOI growth and structural margin pressure from its labour-intensive cold storage model. EPS momentum over 30 days ranks in the 96th percentile — the growth trajectory has impressed — but the 12-month forward EPS trend ranks only in the 27th, suggesting the easy comparisons are fading.
On the stock's recent earnings history, both major 2026 print reactions have been positive. The June result produced a one-day gain of 4.8%; the May result triggered a 9.5% move on the day and held most of that gain over the following week. That pattern of strong earnings reactions makes the current short-building episode an interesting one to watch — shorts adding aggressively into a name that has rewarded bulls on recent results. Its closest peer, COLD, gained 11.5% on the week — slightly better than LINE's 6% — though COLD gave back 2.4% on the final day, broadly in line with the sector's broad pullback.
With no next earnings date yet flagged and the short score at its highest reading of the recent series, the key question going into July is whether the accelerating pace of short-position building stalls or continues, and whether the tightening borrow market eventually makes the cost of maintaining that pressure meaningfully more expensive.
See the live data behind this article on ORTEX.
Open LINE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
